Dry Eye Syndrome Market valued at approximately USD 5.2 billion in 2023 With CAGR of 4.21% by 2030

A Quick Overview of Dry Eye Syndrome Market

The key object of this report on the Dry Eye Syndrome Market is to offer worthy data and a geographical perspective for predictions of market growth in the future. The recommendations added in this detailed report are insightful, and actionable offering a deep understanding of the industry. Moreover, it includes a comprehensive importance of aspects that have impacted the industry.

MarkNtel Advisors has recently studied an extensive market intelligence evaluation on the Dry Eye Syndrome Market. Also, the newly released report exhibits an engaging format that comprises compelling graphs, tables, charts, and figures as well. These seamlessly combined visual aids are designed to support the clarity and accuracy of the details presented, offering analysts a deep knowledge of the topic at hand.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure- - https://www.marknteladvisors.com/query/request-sample/dry-eye-disease-drugs-market.html

Dry Eye Syndrome Market Scenario:

The Global Dry Eye Syndrome Market size is valued at around USD 5.2 billion in 2023 and is projected to grow at a CAGR of around 4.21% during the forecast period, i.e., 2024-30. The growing incidence of this disease globally has been driving the demand for its drugs in the market since the historical years, and this trend is expected to flourish during the forthcoming period as well. Owing to the rise in the geriatric population, increased awareness of the diagnosis & treatment, and an upsurge in the usage of contact lenses, high screen time, etc., are some factors aiding in enhancing the market size.

Dry Eye Syndrome Market - Industry Dynamics, Size, And Opportunity Forecast To 2030:

Market Driver - Growing Number of Eye Care Centers Prompting Surge in Product Utilization

The prevalence of dry eye disease has been increasing worldwide, owing to various reasons such as environmental conditions, hormonal changes, a rise in the geriatric population, autoimmune disorders, etc. This has resulted in a spike in eye clinics & centers globally for treatment. Additionally, the blossoming of eye care centers is majorly driven by the steady boost in professionals, such as ophthalmologists & optometrists. While the number of ophthalmologists is expected to remain stable, the number of optometrists is presumed to raise.

Optometrists offer services through private practices, chain/mass merchandisers, and government organizations. Independent optometrists can differentiate themselves by providing personalized care, building patient loyalty, and offering clinical care. Hence, this allows them to offer a higher level of service to the patients. Thus, the growing number of eye care centers is prompting a surge in product utilization of DED & would propel its demand in the forecast years.

Dry Eye Syndrome Market Segmentation Analysis:

Dry Eye Syndrome Industry, analyzes, identifies, and highlights the main trends and drivers which are affecting each segment of the market. The market has been further divided into the following categories:

By Product

Artificial Tears- Market Size & Forecast 2019-2030, USD Million
Anti-inflammatory Drugs- Market Size & Forecast 2019-2030, USD Million
- Cyclosporine-- Market Size & Forecast 2019-2030, USD Million
- Corticosteroid-- Market Size & Forecast 2019-2030, USD Million
Punctal Plugs- Market Size & Forecast 2019-2030, USD Million
- Dissolvable-- Market Size & Forecast 2019-2030, USD Million
- Removable-- Market Size & Forecast 2019-2030, USD Million
Others (Secretagogues, Oral drugs, etc.)- Market Size & Forecast 2019-2030, USD Million

By Disease Type

Aqueous Dry Eye - Market Size & Forecast 2019-2030, USD Million
Evaporative Dry Eye - Market Size & Forecast 2019-2030, USD Million

By Distribution Channel

Offline- Market Size & Forecast 2019-2030, USD Million
- Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
- Hospital Pharmacies - Market Size & Forecast 2019-2030, USD Million
Online- Market Size & Forecast 2019-2030, USD Million

By Competition

Competition Characteristics
Market Share Analysis

By Region

North America
South America
Europe
Middle East & Africa
Asia-Pacific.

Browse Full Report Along with TOC and Figures - https://www.marknteladvisors.com/research-library/dry-eye-disease-drugs-market.html

Who are the Key Market Players in the Dry Eye Syndrome Market?

In the fast-changing Dry Eye Syndrome Market, understanding what our competitors are doing is crucial. By carefully analyzing things, we figured out some of the dominating players in the industry. So, the top companies of the Dry Eye Syndrome market ruling the industry are:

List of Key Companies Profiled:

Mitotech Pharma
ReGen Tree
Santen Pharmaceutical
HanAll BioPharma
Sun Pharma
Novaliq
Sylentis
Alcon
Horus Pharma
Johnson & Johnson
Alderya Therapeutics
Visufarma
Allergan
Prestige Consumer Health
Others
Others.

Global Dry Eye Syndrome Recent Development:

2023: Novaliq & Bosch+Laumb announced the publication of pivotal phase 3 data of their ophthalmic drug NOVO3, which is developed to treat the signs & symptoms of Dry Eye Disease associated with meibomian gland dysfunction.

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address